Literature DB >> 35420443

Pathological Characteristics of Echovirus 30 Infection in a Mouse Model.

Jichen Li1,2, Guoyan Zhang2, Qiang Sun2, Keyi Zhang2, Huanhuan Lu2, Jinbo Xiao2, Zhenzhi Han2, Hehe Zhao2, Wenbo Xu2,3, Yong Zhang2,3, Zhijun Liu1.   

Abstract

Echovirus 30 (E30), a member of species B enterovirus, is associated with outbreaks of aseptic meningitis and has become a global health emergency. However, the pathogenesis of E30 remains poorly understood due to the lack of appropriate animal models. In this study, we established a mouse infection model to explore the pathogenicity of E30. The 2-day-old IFNAR-/- mice infected with E30 strain WZ16 showed lethargy and paralysis, and some died. Obvious pathological changes were observed in the skeletal muscle, brain tissue, and other tissues, with the highest viral load in the skeletal muscles. Transcriptome analysis of brain and skeletal muscle tissues from infected mice showed that significant differentially expressed genes were enriched in complement response and neuropathy-related pathways. Using immunofluorescence assay, we found that the viral double-stranded RNA (dsRNA) was detected in the mouse brain region and could infect human glioma (U251) cells. These results indicated that E30 affects the nervous system, and they provide a theoretical basis for understanding its pathogenesis. IMPORTANCE Echovirus 30 (E30) infection causes a wide spectrum of diseases with mild symptoms, such as hand, foot, and mouth disease (HFMD), acute flaccid paralysis, and aseptic meningitis and other diseases, especially one of the most common pathogens causing aseptic meningitis outbreaks. We established a novel mouse model of E30 infection by inoculating neonatal mice with clinical isolates of E30 and observed the pathological changes induced by E30. Using the E30 infection model, we found complement responses and neuropathy-related genes in the mice tissues at the transcriptome level. Moreover, we found that the viral dsRNA localized in the mouse brain and could replicate in human glioma cell line U251 rather than in the neuroblastoma cell line, SK-N-SH.

Entities:  

Keywords:  animal model; echovirus 30; pathogenesis

Mesh:

Substances:

Year:  2022        PMID: 35420443      PMCID: PMC9093115          DOI: 10.1128/jvi.00129-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  43 in total

1.  Molecular epidemiology and genetic diversity of echovirus type 30 (E30): genotypes correlate with temporal dynamics of E30 isolation.

Authors:  M S Oberste; K Maher; M L Kennett; J J Campbell; M S Carpenter; D Schnurr; M A Pallansch
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 2.  Blood-brain barrier (BBB) and the complement landscape.

Authors:  Jessy J Alexander
Journal:  Mol Immunol       Date:  2018-07-12       Impact factor: 4.407

Review 3.  Virology, epidemiology, pathogenesis, and control of enterovirus 71.

Authors:  Tom Solomon; Penny Lewthwaite; David Perera; Mary Jane Cardosa; Peter McMinn; Mong How Ooi
Journal:  Lancet Infect Dis       Date:  2010-10-18       Impact factor: 25.071

4.  Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.

Authors:  A Mäenpää; S Junnikkala; J Hakulinen; T Timonen; S Meri
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

5.  Transmission networks and population turnover of echovirus 30.

Authors:  E C McWilliam Leitch; J Bendig; M Cabrerizo; J Cardosa; T Hyypiä; O E Ivanova; A Kelly; A C M Kroes; A Lukashev; A MacAdam; P McMinn; M Roivainen; G Trallero; D J Evans; P Simmonds
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

6.  Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease.

Authors:  Kien Chai Ong; Shamala Devi; Mary Jane Cardosa; Kum Thong Wong
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 7.  Infectious Entry Pathway of Enterovirus B Species.

Authors:  Varpu Marjomäki; Paula Turkki; Moona Huttunen
Journal:  Viruses       Date:  2015-12-07       Impact factor: 5.048

8.  Contemporary Circulating Enterovirus D68 Strains Have Acquired the Capacity for Viral Entry and Replication in Human Neuronal Cells.

Authors:  David M Brown; Alison M Hixon; Lauren M Oldfield; Yun Zhang; Mark Novotny; Wei Wang; Suman R Das; Reed S Shabman; Kenneth L Tyler; Richard H Scheuermann
Journal:  mBio       Date:  2018-10-16       Impact factor: 7.867

9.  A Large-Scale Outbreak of Echovirus 30 in Gansu Province of China in 2015 and Its Phylodynamic Characterization.

Authors:  Jianhua Chen; Zhenzhi Han; Haizhuo Wu; Wenbo Xu; Deshan Yu; Yong Zhang
Journal:  Front Microbiol       Date:  2020-06-10       Impact factor: 5.640

Review 10.  Complement Factors in COVID-19 Therapeutics and Vaccines.

Authors:  Liriye Kurtovic; James G Beeson
Journal:  Trends Immunol       Date:  2020-12-13       Impact factor: 16.687

View more
  1 in total

1.  Transcriptome sequencing analysis of echovirus 30 infection reveals its potential pathogenesis.

Authors:  Qiang Sun; Jichen Li; Bo Zhang; Rui Wang; Congcong Wang; Xiaoliang Li; Ying Liu; Yong Zhang
Journal:  Front Microbiol       Date:  2022-09-06       Impact factor: 6.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.